Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Imaging Services

 

Counting the Cost: The impact of inflation on Europe’s health care market

What impact has the high inflation of the past 18 months had on growth in Europe’s health care market? Have for-profit operators been able to pass on cost increases to payors? And have patients paying out of pocket, in the face of rising prices and squeezed budgets, cut back at all? In this first instalment to answer these questions, we focus on the for-profit hospital, imaging and nursing home sectors in the UK, France and Germany.

See the Global Top 50 by Market Cap

Who are the Global Top 50 Health Care Service Companies by market cap and what does this tell us about the industry? What is striking is how very few of the top 50 are now EMEA companies - just 13, and of those only four are headquartered in Europe, rather than the Middle East or South Africa. 

Two Southeast Asian groups up for sale and an Indian group to IPO

In contrast to Europe, South and Southeast Asia are continuing to see significant deal activity. HBI hears that SAFE Fertility Group, one of Thailand’s largest IVF providers, and Qualitas Medical Group, a primary care chain with practices across Malaysia, Singapore and Australia, are up for sale. On top of this, Agilus Diagnostics, one of India’s largest labs groups, is set to IPO.

UK Government turns to for-profits to bust backlog

The UK independent sector is gearing up for an explosion in backlog-busting public outsourcing. The for-profit hospital, ophthalmology and imaging markets in particular look set for a significant boost according to wide-reaching government plans announced today (January 4). 

Spire boosts its imaging capabilities

Spire Healthcare, the UK’s largest for-profit hospital group, has extended its control over the patient journey with a new state-of-the-art MRI scanner worth £500,000.

HBI 2023: Healthcare Data and the Emergence of Artificial Intelligence: What’s Next?

The hype around artificial intelligence may have reached a new high, but the tools certainly aren’t recent. At HBI 2023, L.E.K. Consulting’s digital health lead Klaus Boehncke and L.E.K. partner Guillaume Duparc shared their perspectives on concerns around privacy and the adoption of AI, as well as advice on how to leverage data effectively.

HBI 2023: AI and Big Data – cutting diagnosis to treatment times

AI and big data are primed to improve clinical outcomes and standards for radiologists as well as the health care sector as a whole, but how far along the journey to automated care delivery are we? In an HBI 2023 panel discussion ‘AI and Big Data: Outcomes and Automation,’ panellists explored how automation could speed up diagnosis to treatment from 2 weeks to 15 minutes.

HBI 2023: Healthcare regulation – opportunities and risks

Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.

Find Us